Published articles

This page contains citations for articles related to vitreous research written by professionals in the scientific and medical community.  New information will be included as soon as it becomes available.  Citations are linked to abstracts and articles whenever possible.  If you have a suggested addition, please contact us.

Vitrectomy

General

• Goldsmith, G., McMullan, T., Burton, T., “Floaterectomy Versus Conventional Pars Plana Vitrectomy For Vitreous Floaters”, Digital Journal of Ophthalmology 2007.
• Hoerauf, Hans; "Vitrectromy Against Floaters." In Essentials in Ophthamology: Vitreo-Retinal Surgery ; Kirchof, B., Wong, D. Eds.; Springer Berlin Heidelberg, 2007; pp. 115-124.
• Cho, Y. J., Lee, J. M., and Kim, S. S., “Vitreoretinal Surgery Using Transconjunctival Sutureless Vitrectomy”, Yonsei Med J, Aug. 2004;45(4):615-620. [Abstract]
• Packo, K, "Early Experience Reveals Benefits of 25-Ga Technology", Rev of Opthalmol, 2004; 11(08).
• Hoerauf, H., Muller, M., & Laqua, H. "Vitreous Body Floaters and Vitrectomy With Full Visual Acuity" Ophthalmologe, 2003;100(8), 639-643. [Abstract]
• Pieter R van den Biesen, T Berenschot, Rudolf M Verdaasdonk, Huib van Weelden, D van Norren, “Endoillumination During Vitrectomy and Phototoxicity Thresholds”, Br J Ophthalmol 2000;84:1372-1375 ( December ). [Abstract]
• Schiff, W.M., Chang, S., Mandava, N., & Barile, G.R. "Pars Plana Vitrectomy for Persistent, Visually Significant Vitreous Opacities", Retina, 2000;20(6), 591-596. [Abstract]

Enzymatic/Pharmacologic

• De Smet, M.D., "Pharmacologic Vitreolysis: The Goal Defines the Means", Retinal Physician, May, 2009. Web Aug. 18, 2009
• Gandorfer A., "Enzymatic Vitreous Disruption", Eye. 2008;22:1273-1277. [Abstract]
• Trese, M. T., “Enzymatic-Assisted Vitrectomy”, Eye, 2002, 16(4):365-8.
• Sebag, J., "Pharmacologic Vitreolysis", Retina, 1998, 18(1):1.
• Díaz-Llopis, M. and Cervera, E., “Posterior Vitreous Detachment and Pharmacologic Vitreolysis: The New Age of Enzymatic Vitrectomy”, Arch Soc Esp Oftalmol, 2007; 82: 465-466.
• Nazari, H., et. al., “Pharmacologic Vitreolysis” J Ophthalmic Vis Res 2010; 5 (1): 44-52.

Laser Treatment(s)

• Karickhoff, John. Laser Treatment of Eye Floaters, Washington Medical Publishing, LLC, 2005.
• Y.M., Delaney, Oyinloye, A., Benjamin, L., “Nd:YAG Vitreolysis and Pars Plana Vitrectomy: Surgical Treatment for Vitreous Floaters”, Eye, Jan. 2002;16(1):21-26.
• Vandorselaer, T., Van De Velde, F., Tassignon., M. J., “Eligibility Criteria for Nd:YAG Laser Treatment of Highly Symptomatic Vitreous Floaters”, Bull Soc Belge Ophtalmol, 2001;(280):15-9. [Abstract]
• Tsai, Wu-Fu "Treatment of Vitreous Floaters with Neodymium YAG Laser", British Journal of Ophthalmology 1993; 77:485-488. [Abstract]
• Tassignon, MJ "Indications for Q-Switched and Mode-Locked Nd:YAG Lasers in Vitreoretinal Pathology", European Journal of Ophthalmology 1991; vol. 1/no. 3: 123-130. [Abstract]
• Little, H. L. "Q-Switched Neodymium: YAG Laser Surgery of the Vitreous" Graefe's Arch Clin Exp Ophthalmol 1986 224: 240-246. [Abstract]
• Fankhauser, Franz "Vitreolysis with the Q-Switched Laser" Arch Ophthalmology 1985 103:1166-1171. [Abstract]
• Aron-Rosa, Daniele "Neodymium: YAG Laser Vitreolysis", Int. Ophthal. Clinics 1985 25:125-134. [Abstract]

The Vitreous

Composition & Function

• Sebag, J., "Vitreoschisis", Editorial in Graefes Archives Clin Exp Ophthalmology (2008) 246:329-33.
• Lombardo, J. "Understanding The Vitreous", Optometry Times, Feb 10, 2006, pp 44-47.
• Bishop, P. N., Takanosu, M., le Goff, M., and Mayne, R., “The Role of the Posterior Ciliary Body in the Biosynthesis of Vitreous Humor”, Eye, 2002;16, 454-460.
• Sebag, J., "Imaging Vitreous", Eye, 2002;16, 429–439.
• Takano, A., Osanai, Y., Ohnishi, M., & Akiba, J. "Characteristics of Floaters and Indicative of Posterior Vitreous Detachment"  Rinsho Ganka, 2000;54(1), 79-82. [Abstract]
• Scott, J.E., “Secondary and Tertiary Structures of Hyaluronan in Aqueous Solution. Some Biological Consequences.” Glycoforum, Mar. 15, 1998.
• Sebag, J., and Balazs, E.A., "Morphology and Ultrastructure of Human Vitreous Fibers", Inves Opthalmol & Vis Sci,1989 (30)8:1867-1871.
• J. Sebag, "Age Related Changes in Human Vitreous Structure", Graefe's Arch Clin Exp Ophthalmology (1987) 225:89-93.
• Sebag, J., and Balazs, E.A., "Human Vitreous Fibres and Vitreoretinal Disease", Trans Ophthalmol Soc UK,1985 (104)123.
• Eggers, H. "Lipotropic Substances for Absorption of Vitreous Opacities" New York Journal of Medicine, 1951;51, 2255.

Replacement

• Matteucci, A., Formisano, G., Paradisi, G., Carnovale-Scalzo, G., Scorcia, G., Caiazza, H., Hoerauf, H., Malchiodi-Albedi F., “Biocompatibility Assessment of Liquid Artificial Vitreous Replacements: Relevance of In Vitro Studies”, Surv Ophthalmol, 2007; 52:289-299. [Abstract]
• Gao, Q., Mou, S., Ge, J., To, C-h., Hui, Y., Liu, A., Wang, Z., Long, C., and Tan, J., “A New Strategy to Replace the Natural Vitreous by a Novel Capsular Artificial Vitreous Body with Pressure-Control Valve”, Eye advance online publication, 25 May 2007.
• Soman, N., and Banerjee R., “Artificial Vitreous Replacements”, Bio-Medical Materials and Engineering, 2003;13:59-74. [Abstract]

Review Articles

• Polkinghorne, P., "Vitreous Floaters: When a Minor Nuisance Becomes a Major Issue", Retinal Physician, May, 2009. Web Aug. 18, 2009, <http://www.retinalphysician.com/article.aspx?article=102990>
• Polkinghorne, P. and Roufail, E.D., "Vitreous Floaters", Compr Ophthalmol Update. 2006;7:171-177. [Abstract]
• Sendrowski, D.P., and Bronstein, M.A., "Current Treatment for Vitreous Floaters" Optometry (2010) 81, 157-161.